Partnerships Growth Ambry's CARE program and its partnership with the Child Neurology Foundation highlight a strong, workflow driven solution for cancer risk assessment and genetic testing. This creates an opportunity to target health systems, academic centers, and neurology oncology clinics with enterprise licenses and integrated decision support. There is potential for pharma collaborations to leverage Ambry's expanding genomic database for biomarker discovery and trial enrichment.

Informatics Cred MedTech Breakthrough 2026 naming CARE as the Best Overall Health Informatics Solution adds credibility when engaging CIOs and informatics leaders. Use this achievement to position CARE as an EMR and EHR integrated platform and secure data exchange with governance and compliance tooling such as OneTrust and MasterControl.

Scale Opportunity Ambry's sizable revenue and patient volumes point to upsell opportunities for expanded panels, pharmacogenomics, and carrier screening within integrated care plans across large health systems, lab networks, and oncology programs. Pitch enterprise pricing and multi site deployment supported by a cloud native, scalable platform.

Platform Synergies Ambry's corporate connections within Tempus Flatiron ecosystems offer potential cross sell opportunities to customers already using precision medicine platforms. Propose joint offerings that combine genomic testing with rich clinical data and analytics to support pharma collaborations and trial readiness.

Market Expansion Recent CARE enhancements and strategic partnerships indicate a path to broaden CARE adoption into radiology, pediatric neurology, and broader oncology workflows. Target imaging centers, community hospitals, and academic centers to deploy CARE and expand patient access to genomic testing and risk assessment.